Dr. Borna Mehrad, MD

Dr. Mehrad practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Mehrad's NPI, 1164485892, was assigned on April 12, 2006. Dr. Mehrad graduated from University of Nottingham Medical School in 1991. Dr. Mehrad holds Florida license ME132544.

Dr. Mehrad's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Mehrad's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehrad practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehrad's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mehrad is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mehrad's licenses on file in 5 states: Florida, Virginia, Texas, Michigan and Pennsylvania.

CMS data shows 377 Medicare services from Dr. Mehrad across 8 procedure codes in 2024, for 170 Medicare patients. Medicare paid $40,633 for them.

CMS counts 170 Medicare patients who saw Dr. Mehrad in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehrad's median patient age at 71, with 53% women.

In 2024, Dr. Mehrad wrote 379 Medicare Part D claims for 77 patients. 69% of them were for generic drugs. CMS names the drug for 309 of them, across 10 drugs with 11 or more claims each, at $1,093,251 in total drug cost. In 2023, CMS named 314 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Mehrad for performance year 2024, reported through an alternative payment model (APM). Dr. Mehrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 133 papers to Dr. Mehrad, published from 2007 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Lung, Aspergillosis and Mice, Inbred C57BL. Dr. Mehrad has published most often in J Immunol. Dr. Mehrad's most frequent co-authors are Ellen Catherine Keeley, MD, Mark Louis Brantly, MD and Divya Chandrakant Patel, DO.

Dmand AI links Dr. Mehrad to 2 clinical trials. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 8 general payments to Dr. Mehrad from 1 drug or device company in 2025. Consulting fees make up the largest share, 53% of the total. Polarean, Inc. paid the most, $4,709.

Dmand AI lists 1 award for Dr. Mehrad, most recently CMS Stage 1 EHR in 2013.

Dr. Mehrad graduated from University of Nottingham Medical School in 1991.

Dr. Mehrad is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.